FDA 483 - The EF Precision Group - July 02, 2021

An FDA inspection of The EF Precision Group, a contract manufacturer in Willow Grove, PA, revealed two significant issues. The firm failed to adequately document corrective and preventive action activities, specifically regarding the verification of effectiveness for several corrective actions. Additionally, the company did not document and approve process validation activities, particularly for a cleaning process used on manufactured parts.